Cannabis is a psychoactive drug produced by the Cannabis plant. The effects of the drug are caused by a group of compounds known as cannabinoids, of which THC and CBD are the most widely known.
Due to its long-standing designation as a controlled substance, there are very few scientific studies regarding the potential medical applications of cannabis. Despite this, there is preliminary evidence that cannabis may be used to help alleviate cancer-associated pain.
This study represents the first clinical trial of cannabis for the treatment of poorly controlled pain among cancer patients.
Patients enrolling on this trial will receive a whole-plant cannabis oil extract, taken as a capsule once per day. This will be administered as an add-on therapy to your current treatment regimen.
Patients will receive increasing doses until a sustained pain response is reached, after which they will be monitored for safety and the durability of their pain response for 12 weeks.
- Age 25-70 years
- Cancer has not spread to the brain
- No prior use of cannabis within 30 days of trial enrollment
Additional eligibility criteria may apply. Please speak to your doctor.Find out more about this study.
|Hospital / Cancer Centre||Principal Investigator||Location||Trial Status|
|Hospital / Cancer CentreJuravinski Cancer Centre||Principal InvestigatorDr. Marissa Slaven||LocationHamilton, Ontario||Trial StatusRecruiting|